Clinical Trial Update: Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study) [Phase 4]

View source ↗

Summary

Phase 4 GLOBAL study evaluating angiotensin II receptor blockade for left ventricular function after acute myocardial infarction; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Angiotensin-II Receptor Blocker (angiotensin II receptor blocker)

Snippet

Sponsor: University of Southern Denmark | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED